Login / Signup

Study protocol for a randomised controlled trial evaluating the effects of the orexin receptor antagonist suvorexant on sleep architecture and delirium in the intensive care unit.

Omid AzimaraghiMaximilian HammerPeter SanterKatharina PlatzbeckerFriederike C AlthoffMaria PatrocinioStephanie D GrabitzKaruna WongtangmanSandra RumyantsevXinling XuMaximilian S SchaeferPatrick M FullerBalachundhar SubramaniamMatthias Eikermann
Published in: BMJ open (2020)
This trial has been registered at clinicaltrials.gov on 17 September 2019 (NCT04092894).
Keyphrases
  • phase iii
  • study protocol
  • phase ii
  • cardiac surgery
  • clinical trial
  • sleep quality
  • physical activity
  • hip fracture
  • randomized controlled trial
  • open label
  • acute kidney injury
  • double blind
  • placebo controlled